TrialRheumatology (Oxford, England)2021

Adverse effects related to methotrexate polyglutamate levels: adjudicated results from the cardiovascular inflammation reduction trial.

Chang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.